Analysis of MicroRNA Signature Differentially Expressed in Pancreatic Islet Cells Treated with Pancreatic Cancer-Derived Exosomes

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Sep 28

PMID 37762604

Authors

Young-Gon Kim

Jisook Park

Eun Young Park

Sang-Mi Kim

Soo-Youn Lee

Affiliations

Soon will be listed here.

Abstract

Since the majority of patients with pancreatic cancer (PC) develop insulin resistance and/or diabetes mellitus (DM) prior to PC diagnosis, PC-induced diabetes mellitus (PC-DM) has been a focus for a potential platform for PC detection. In previous studies, the PC-derived exosomes were shown to contain the mediators of PC-DM. In the present study, the response of normal pancreatic islet cells to the PC-derived exosomes was investigated to determine the potential biomarkers for PC-DM, and consequently, for PC. Specifically, changes in microRNA (miRNA) expression were evaluated. The miRNA specimens were prepared from the untreated islet cells as well as the islet cells treated with the PC-derived exosomes (from 50 patients) and the healthy-derived exosomes (from 50 individuals). The specimens were subjected to next-generation sequencing and bioinformatic analysis to determine the differentially expressed miRNAs (DEmiRNAs) only in the specimens treated with the PC-derived exosomes. Consequently, 24 candidate miRNA markers, including IRS1-modulating miRNAs such as hsa-miR-144-5p, hsa-miR-3148, and hsa-miR-3133, were proposed. The proposed miRNAs showed relevance to DM and/or insulin resistance in a literature review and pathway analysis, indicating a potential association with PC-DM. Due to the novel approach used in this study, additional evidence from future studies could corroborate the value of the miRNA markers discovered.

Citing Articles

Exosomal microRNA as a key regulator of PI3K/AKT pathways in human tumors.

Jasim S, Ahmed A, Kubaev A, Kyada A, Alshahrani M, Sharma S Med Oncol. 2024; 41(11):265.

PMID: 39400677 DOI: 10.1007/s12032-024-02529-9.

A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment.

Trifylli E, Kriebardis A, Koustas E, Papadopoulos N, Fortis S, Tzounakas V Int J Mol Sci. 2024; 25(6).

PMID: 38542378 PMC: 10969997. DOI: 10.3390/ijms25063406.

References

Sah R, Nagpal S, Mukhopadhyay D, Chari S . New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol. 2013; 10(7):423-33. PMC: 3932322. DOI: 10.1038/nrgastro.2013.49. View

Guo X, Xiao F, Li J, Zhou Y, Zhang W, Sun B . Exosomes and pancreatic diseases: status, challenges, and hopes. Int J Biol Sci. 2019; 15(9):1846-1860. PMC: 6743302. DOI: 10.7150/ijbs.35823. View

Klein E, Richards D, Cohn A, Tummala M, Lapham R, Cosgrove D . Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021; 32(9):1167-1177. DOI: 10.1016/j.annonc.2021.05.806. View

Hart P, Bellin M, Andersen D, Bradley D, Cruz-Monserrate Z, Forsmark C . Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol. 2017; 1(3):226-237. PMC: 5495015. DOI: 10.1016/S2468-1253(16)30106-6. View

Miyazaki S, Tashiro F, Tsuchiya T, Sasaki K, Miyazaki J . Establishment of a long-term stable β-cell line and its application to analyze the effect of Gcg expression on insulin secretion. Sci Rep. 2021; 11(1):477. PMC: 7804151. DOI: 10.1038/s41598-020-79992-7. View

Han Q, Li W, Hu K, Gao J, Zhai W, Yang J . Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer. 2022; 21(1):207. PMC: 9623991. DOI: 10.1186/s12943-022-01671-0. View

Kimple M, Keller M, Rabaglia M, Pasker R, Neuman J, Truchan N . Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion. Diabetes. 2013; 62(6):1904-12. PMC: 3661627. DOI: 10.2337/db12-0769. View

Zhang H, Xing J, Dai Z, Wang D, Tang D . Exosomes: the key of sophisticated cell-cell communication and targeted metastasis in pancreatic cancer. Cell Commun Signal. 2022; 20(1):9. PMC: 8760644. DOI: 10.1186/s12964-021-00808-w. View

Park J, Go E, Oh J, Lee J, Lee S . Multiple-Cycle Polymeric Extracellular Vesicle Precipitation and Its Evaluation by Targeted Mass Spectrometry. Int J Mol Sci. 2021; 22(9). PMC: 8122279. DOI: 10.3390/ijms22094311. View

10.

Liu M, Gao J, Huang Q, Jin Y, Wei Z . Downregulating microRNA-144 mediates a metabolic shift in lung cancer cells by regulating GLUT1 expression. Oncol Lett. 2016; 11(6):3772-3776. PMC: 4888127. DOI: 10.3892/ol.2016.4468. View

11.

Mononen N, Lyytikainen L, Seppala I, Mishra P, Juonala M, Waldenberger M . Whole blood microRNA levels associate with glycemic status and correlate with target mRNAs in pathways important to type 2 diabetes. Sci Rep. 2019; 9(1):8887. PMC: 6586838. DOI: 10.1038/s41598-019-43793-4. View

12.

Javeed N, Sagar G, Dutta S, Smyrk T, Lau J, Bhattacharya S . Pancreatic Cancer-Derived Exosomes Cause Paraneoplastic β-cell Dysfunction. Clin Cancer Res. 2014; 21(7):1722-33. PMC: 4383684. DOI: 10.1158/1078-0432.CCR-14-2022. View

13.

Rahimi R, Malek I, Lerrer-Goldshtein T, Elkis Y, Shoval I, Jacob A . TMF1 is upregulated by insulin and is required for a sustained glucose homeostasis. FASEB J. 2021; 35(2):e21295. DOI: 10.1096/fj.202001995R. View

14.

Pegtel D, Peferoen L, Amor S . Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain. Philos Trans R Soc Lond B Biol Sci. 2014; 369(1652). PMC: 4142037. DOI: 10.1098/rstb.2013.0516. View

15.

Zhou W, Deng Y, Zhao H, Zhang C . Current Status of Serum Insulin and C-Peptide Measurement in Clinical Laboratories: Experience from 94 Laboratories in China. Ann Lab Med. 2022; 42(4):428-437. PMC: 8859554. DOI: 10.3343/alm.2022.42.4.428. View

16.

Karolina D, Armugam A, Tavintharan S, Wong M, Lim S, Sum C . MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One. 2011; 6(8):e22839. PMC: 3148231. DOI: 10.1371/journal.pone.0022839. View

17.

Kozomara A, Griffiths-Jones S . miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2013; 42(Database issue):D68-73. PMC: 3965103. DOI: 10.1093/nar/gkt1181. View

18.

Langmead B, Trapnell C, Pop M, Salzberg S . Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009; 10(3):R25. PMC: 2690996. DOI: 10.1186/gb-2009-10-3-r25. View

19.

Perera C, Falasca M, Chari S, Greenfield J, Xu Z, Pirola R . Role of Pancreatic Stellate Cell-Derived Exosomes in Pancreatic Cancer-Related Diabetes: A Novel Hypothesis. Cancers (Basel). 2021; 13(20). PMC: 8534084. DOI: 10.3390/cancers13205224. View

20.

Pan Y, Tang H, Li Q, Chen G, Li D . Exosomes and their roles in the chemoresistance of pancreatic cancer. Cancer Med. 2022; 11(24):4979-4988. PMC: 9761084. DOI: 10.1002/cam4.4830. View